Joint replacements are the #1 expenditure of Medicare. The process of approving these medical devices is flawed according to the Institute of Medicine. It is time for patients' voices to be heard as stakeholders and for public support for increased medical device industry accountability and heightened protections for patients. Post-market registry. Product warranty. Patient/consumer stakeholder equity. Rescind industry pre-emptions/entitlements. All clinical trials must report all data.
Please share what you have learned!
Twitter: @JjrkCh

Thursday, June 12, 2014

Harmed Patients Notified of/Included in a 'Groundbreaking Conference'?

Evidence for New Medical Products:
Implications for Patients and Health Policy
Date: June 13th, 2014
Time: 8:30 a.m. – 6:00 p.m.
Location: American Association for the Advancement of Science, Washington, D.C.
Register here:
This event is co-sponsored by the American Association for the Advancement of Science, Division of Pharmacoepidemiology and Pharmacoeconomics of Brigham and Women’s Hospital/Harvard Medical School, and National Center for Health Research.
Conference Focus
Better implementation of evidence-based medicine can improve the quality and cost-effectiveness of health care in the U.S. This can be challenging in evaluating newly approved drugs and medical devices. While current law requires that medical products be proven safe and effective, there is growing pressure to expedite access to promising therapies and to lessen the research and regulatory requirements for manufacturers. Unmet medical needs and patient demands call for a flexible approach to prescription drug and device regulation, but truncated premarket review may also lead to approval of products that are less effective than expected or have unanticipated safety problems. This groundbreaking conference will review the growing body of research on the medical and public health implications of medical product approval criteria, and examine these findings in the context of patient outcomes, costs, and health policy.
Confirmed Speakers Include (where are the harmed patient speakers?)
Jerry Avorn, MD, Professor, Harvard Medical School; Greg Curfman, MD, Executive Editor, New England Journal of Medicine; Congresswoman Rosa DeLauro; Aaron Kesselheim, MD, Harvard Medical School; Bernard Lo, MD, President, Greenwall Foundation; Rita Redberg, MD, Editor, JAMA Internal Medicine; Joseph Ross, MD, Yale Medical School; Patrick Ryan, PhD, Janssen Research and Development; Sebastian Schneeweiss, MD, Harvard Medical School; Lisa Schwartz, MD, Dartmouth; Joe Selby, MD, Executive Director, Patient Centered Outcomes Research Institute; Steven Woloshin, MD, Dartmouth; Robert Yarchoan, MD, National Cancer Institute; Diana Zuckerman, PhD, National Center for Health Research.

For more details on the program and registration, please go to There is no cost for attending the event, but space is limited and advance registration is required.

No comments:

Post a Comment